SCHEMBL24435291

SCHEMBL24435291

COC(=O)c1cc(C=O)cn1Cc1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 2/20 0.52
USP2 O75604 1/20 0.52
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28673167 0.83 USP2 (0.55) MAPK10USP2CYP11B1CYP11B2CCNC
SCHEMBL24937330 0.82 MAPK10 (0.54) MAPK10USP2CYP11B1CYP11B2CCNC
SCHEMBL16320824 0.78 ALDH1A1 (0.42) HDAC1HDAC8ALDH1A1KDM4EMAPT
SCHEMBL16116241 0.76 CCNC (0.71) MAPK10USP2CYP11B1CYP11B2CCNC
SCHEMBL25395065 0.74 USP2 (0.51) MAPK10USP2CYP11B1CYP11B2HDAC3
SCHEMBL28683880 0.74 CYP11B1 (0.70) MAPK10USP2CYP11B1CYP11B2HDAC3
SCHEMBL28932116 0.74 USP2 (0.43) MAPK10USP2CYP11B1CYP11B2ALDH1A1
SCHEMBL25372074 0.73 SMN1; SMN2 (0.37) MAPK10ALDH1A1KDM4EMAPTNPSR1
SCHEMBL20139218 0.73 ALDH1A1 (0.38) HDAC8ALDH1A1KDM4EMAPTBRD4
SCHEMBL10565454 0.73 ALDH1A1 (0.38) HDAC8ALDH1A1KDM4EMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed
CN-113993587-A Thiazole derivatives as protein secretion inhibitors 科智生命科学公司 2022-01-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G MAPK10 730/4885USP2 1151/4885CYP11B1 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.